Hai Ming Zhang
Chairman presso SHANGHAI HILE BIO-TECHNOLOGY CO., LTD.
Provenienza dei contatti di primo grado di Hai Ming Zhang
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
6 Dimensions Capital
 6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017.
30
| Holding Company | Investment Managers | 30 |
| Public Company | Pharmaceuticals: Major | 10 | |
Yangling Jinhai Biotechnology Co., Ltd.
 Yangling Jinhai Biotechnology Co., Ltd. BiotechnologyHealth Technology Yangling Jinhai Biotechnology Co., Ltd. is a company based in Xianyang, China. The Chinese company specializes in biotechnology and offers a range of products, including a vaccine for foot-and-mouth disease in pigs. The company was founded in 2013, and the CEO is Hai Ming Zhang.
6
| Holding Company | Biotechnology | 6 |
Shanghai Yaoming Haide Biotechnology Co., Ltd.
 Shanghai Yaoming Haide Biotechnology Co., Ltd. Medical DistributorsDistribution Services Shanghai Yaoming Haide Biotechnology Co., Ltd. is a private company that sells medical equipment and laboratory equipment. The company is based in Shanghai, China and was founded in 2018.
3
| Private Company | Medical Distributors | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Hai Ming Zhang tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| WUXI PHARMATECH (CAYMAN) INC. (ADR) | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
China Life Sciences Access Fund LP
 China Life Sciences Access Fund LP Investment ManagersFinance China Life Sciences Access Fund LP is a venture capital fund that operates in the life sciences industry. The private company is based in George Town, Cayman Islands. | Investment Managers | Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree Masters Business Admin Masters Business Admin | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree Undergraduate Degree | |
| AMBRX INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Xi'an Jiaotong University | College/University | Undergraduate Degree Doctorate Degree | |
| Fudan University | College/University | Masters Business Admin Doctorate Degree Graduate Degree | |
| WUXI APPTEC CO., LTD. | Pharmaceuticals: Major | Chief Investment Officer Chief Executive Officer Chief Executive Officer | |
International Society for Pharmaceutical Engineering
 International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Director/Board Member | |
| Université Catholique de Louvain | College/University | Doctorate Degree | |
Shanghai Celgen Bio-pharmaceutical Co., Ltd.
 Shanghai Celgen Bio-pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Celgen Bio-pharmaceutical Co., Ltd. develops and manufactures biopharmaceutical products. The firm's products include Monoclonal Antibody (MAB) used for the treatment of inflammatory conditions such as rheumatoid, juvenile rheumatoid & psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. The company was founded on November 6, 2000 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Chief Operating Officer | |
Shanghai Huazhou PSA Products Co., Ltd.
 Shanghai Huazhou PSA Products Co., Ltd. Industrial SpecialtiesProcess Industries Shanghai Huazhou PSA Products Co., Ltd. engages in the manufacture and sale of medical tapes and dressings. It specializes in medial tape, breathable tape, medical dressings, microwave door paste, cloth tape, aluminum foil tape, sanitary napkins tape, and breathable composite products. The company was founded on May 15, 2002 and is headquartered in Shanghai, China. | Industrial Specialties | Director/Board Member Chairman | |
Shanghai Syn-the-all Pharmaceutical Co. Ltd.
 Shanghai Syn-the-all Pharmaceutical Co. Ltd. Pharmaceuticals: GenericHealth Technology Shanghai Syn-the-all Pharmaceutical Co. Ltd. engages in the manufacture, research and development of generic drugs. The company offers active pharmaceutical ingredients and finished forms. It provides API process development, small molecule Active pharmaceutical ingredients, analytical development and quality control, antibody drug conjugate services. It serves life science industry. Shanghai Syn-the-all Pharmaceutical was founded on January 23, 2003 and is headquartered in Shanghai, China. | Pharmaceuticals: Generic | Director/Board Member Chairman | |
| Eli Lilly Asia, Inc. | Corporate Officer/Principal | ||
Kanda Biotech Holdings Ltd.
 Kanda Biotech Holdings Ltd. Financial ConglomeratesFinance Kanda Biotech Holdings Ltd. provides financial services. | Financial Conglomerates | President | |
| HUA MEDICINE (SHANGHAI) LTD. | Pharmaceuticals: Major | Founder Director/Board Member | |
| INNOVENT BIOLOGICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ADAGENE INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Fjord Holding LLC
 Fjord Holding LLC Medical/Nursing ServicesHealth Services NextCODE Health LLC provides clinical diagnosis services. It is a sequence-based clinical diagnostics company delivering a powerful solution to genome interpretation and big data challenges. The company was founded in 2013 by Jeffrey Gulcher and Hannes Thor Smarason and is headquartered in Cambridge, MA. | Medical/Nursing Services | Chief Executive Officer Chairman | |
| NEUSOFT XIKANG HOLDINGS INC. | Data Processing Services | Director/Board Member | |
Wuxi Apptec, Inc.
 Wuxi Apptec, Inc. Data Processing ServicesTechnology Services Wuxi Apptec, Inc. provides pharmaceutical and biotechnology services. Its services include discovery, lab testing division, small molecule pharmaceutical development and manufacturing international discovery service unit, WuXi biologics, chemistry, bioanalytical, clinical & regulatory, genome center, biological reagents and WuXi venture fund. The company was founded by Ge Li in December 2000 and is headquartered in St. Paul, MN. | Data Processing Services | Chief Investment Officer Chief Investment Officer | |
Fog Pharmaceuticals, Inc.
 Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member | |
TenNor Therapeutics Suzhou Ltd.
 TenNor Therapeutics Suzhou Ltd. Pharmaceuticals: GenericHealth Technology TenNor Therapeutics Suzhou Ltd. manufactures pharmaceutical products. It specializes in research and development of new drugs for the treatment of digestive diseases caused by pathogens, including those resistant to available antibiotics. The company was founded by Zhen Kun Ma in 2013 and is headquartered in Suzhou, China. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
| JW Biotechnology (Shanghai) Co. Ltd. | Director/Board Member Chairman | ||
WuXi AppTec (Shanghai) Co. Ltd.
 WuXi AppTec (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of WuXi AppTec Co., Ltd., WuXi AppTec (Shanghai) Co. Ltd. develops and manufactures pharmaceuticals. The private company is based in Shanghai, China. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CSTONE PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
LifeMine Therapeutics, Inc.
 LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
| WUXI BIOLOGICS (CAYMAN) INC. | Biotechnology | Director/Board Member Chairman Chief Executive Officer General Counsel | |
Wuxi Biologics Holdings Ltd.
 Wuxi Biologics Holdings Ltd. Financial ConglomeratesFinance Wuxi Biologics Holdings Ltd. functions as an investment holding There is no available country named vg company. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Wuxi New Life Science Investment Ltd.
 Wuxi New Life Science Investment Ltd. Financial ConglomeratesFinance Wuxi New Life Science Investment Ltd. is a Chinese company that provides investment services. The private company is based in Shanghai, China. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Engine Biosciences Pte Ltd.
 Engine Biosciences Pte Ltd. BiotechnologyHealth Technology Engine Biosciences Pte Ltd. develops novel combinations of genes and drugs for therapeutic and industrial purposes. The company was founded by Timothy Lu and Jeffrey Lu and is headquartered in Singapore. | Biotechnology | Director/Board Member | |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member Chairman | |
| 111, INC. | Medical Distributors | Director/Board Member | |
| Hua Medicine Technology (Hong Kong) Ltd. | Director/Board Member | ||
Hua Medicine (Shanghai) Co., Ltd.
 Hua Medicine (Shanghai) Co., Ltd. BiotechnologyHealth Technology Hua Medicine (Shanghai) Co., Ltd. is a Chinese biotechnology company that focuses on the clinical needs of diabetic patients. The private company is based in Shanghai, China. The company has brought together high-end talents and scientific and technological resources to develop the world's first dorzagliatin (hms5552) for the treatment of type 2 diabetes. Hua Medicine has conducted two phase III clinical trials in 2019, targeting type 2 diabetes patients who have failed to treat the disease with other medications. The company plans to expand the advanced concepts of personalized therapy and management of diabetes to achieve effective control of diabetes and metabolic diseases and complications. The company was founded in 2011 by Li Chen, who has been the CEO since then. | Biotechnology | Director/Board Member Director/Board Member | |
| FIL Capital Management (Hong Kong) Ltd. | Corporate Officer/Principal | ||
| OCUMENSION THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Chairman | |
Creacion Ventures Management LLC
 Creacion Ventures Management LLC Investment ManagersFinance Creacion Ventures Management LLC (Creacion Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
WuXi Vaccines Ireland Ltd.
 WuXi Vaccines Ireland Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Wuxi Biologics (Cayman), Inc., WuXi Vaccines Ireland Ltd. discovers, develops and manufactures human vaccines. The private company is based in Dundalk, Ireland. The CEO of the Irish company is Jian Dong. | Miscellaneous Commercial Services | Chairman | |
Hua Medtech Medical Devices (Shanghai) Co., Ltd.
 Hua Medtech Medical Devices (Shanghai) Co., Ltd. Medical SpecialtiesHealth Technology Hua Medtech Medical Devices (Shanghai) Co., Ltd. provides stroke diagnosis, treatment, and rehabilitation services. The private company is based in Shanghai, China. The Chinese company was founded in 2017. Wei Zhang has been the CEO of the company since 2020. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| WUXI XDC CAYMAN INC. | Miscellaneous Commercial Services | Chairman | |
| CANBRIDGE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CUTIA THERAPEUTICS | Pharmaceuticals: Major | Chairman | |
Phagelux, Inc.
 Phagelux, Inc. BiotechnologyHealth Technology Phagelux, Inc. develops anti-bacterial solutions. It specializes across multiple fields utilizing various phage and phage-based technologies and solutions. The company is headquartered in Shanghai, China. | Biotechnology | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Cina | 25 |
| Stati Uniti | 14 |
| Isole Cayman | 8 |
| Hong Kong | 3 |
| Belgio | 2 |
Settori
| Health Technology | 26 |
| Finance | 7 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 127 |
| Corporate Officer/Principal | 32 |
| Private Equity Investor | 26 |
| Founder | 23 |
| Chairman | 21 |
Contatti più connessi
| Insiders | |
|---|---|
| Edward Hu | 29 |
| Gregory Verdine | 25 |
| Wei Li | 24 |
| Lian Yong Chen | 24 |
| Ge Li | 23 |
| Zhi Sheng Chen | 15 |
| Hannes Thor Smárason | 11 |
| Tian Min Liu | 11 |
| Qing Sheng Zhu | 11 |
| Xiao Le | 8 |
| Cheng Li | 7 |
| Dong Chan Pu | 6 |
| Lin Ni | 5 |
| Ben Yi Han | 5 |
| Xiao Chen | 4 |
- Borsa valori
- Insiders
- Hai Ming Zhang
- Connessioni Società
